UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

__________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  March 22, 2012

The Female Health Company
(Exact name of registrant as specified in its charter)

Wisconsin
  
1-13602
  
39-1144397
(State or other jurisdiction
of incorporation)
  
(Commission File Number)
  
(IRS Employer
Identification No.)

515 North State Street, Suite 2225, Chicago, Illinois 60654
(Address of principal executive offices, including zip code)

(312) 595-9123
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 


Section 5 – Corporate Governance and Management
 
Item 5.07.     Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Shareholders of The Female Health Company (the "Company") was held on March 22, 2012.  A total of 27,928,089 shares of common stock were eligible to vote at the Annual Meeting.  The matters voted on at the Annual Meeting were as follows:

1.    Election of Directors:

The following individuals were nominated for election to the Board of Directors for terms that expire at the next annual meeting of shareholders.

 
Name
  
Votes
      For      
  
Votes
    Withheld    
  
Broker
   Non-Votes   
David R. Bethune
  
14,354,549
  
142,867
  
8,467,714
Stephen M. Dearholt
  
14,379,130
  
118,286
  
8,467,714
Mary Margaret Frank, Ph.D.
  
14,385,822
  
111,594
  
8,467,714
William R. Gargiulo, Jr.
  
14,375,597
  
121,819
  
8,467,714
Mary Ann Leeper, Ph.D.
  
13,986,583
  
510,833
  
8,467,714
O.B. Parrish
  
14,406,988
  
90,428
  
8,467,714
Michael R. Walton
  
14,374,796
  
122,620
  
8,467,714
Richard E. Wenninger   14,379,528  
117,888
   8,467,714

The nominations were made by the Board of Directors and no other nominations were made by any shareholder. The nominees had currently been members of the Board of Directors at the date of the Annual Meeting.

2.     Ratification of Auditors:

The shareholders voted to ratify the appointment by the Company's Audit Committee of McGladrey & Pullen, LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2012.

    Votes For    
  
  Votes Against
  
    Abstentions  
  
   Broker Non-Votes  
22,881,831
  
19,913
  
63,386
  
–


 
2 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE FEMALE HEALTH COMPANY

Date:  March 27, 2012
BY /s/ Donna Felch                                                      
       Donna Felch, Vice President and
Chief Financial Officer
 
3